NRAS and pneumocystosis: The single patient with an NRAS mutation who did not die of an infection nevertheless had an episode of severe and prolonged neutropenic sepsis after her first course of chlorambucil, followed by pneumocystis pneumonia 3 years later after completing second-line treatment with fludarabine.